Posts

Showing posts from July, 2025

Virtual Biopsy Market 2025–2034 – M&A Opportunities, AI Integration, and Competitive Benchmarking

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the virtual biopsy industry over the next few years? The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing demand for non-invasive diagnostic methods, growing preference for early disease detection, rising efficiency in medical imaging software, increasing patient convenience and comfort, and rising availability of telemedicine services. The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to a growing focus on cost-effective healthcare solutions, a growing focus on...

Topoisomerase I Inhibitors Market Forecast 2025 – Strategic Insights and Pipeline Expansion Trends

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the topoisomerase i inhibitors industry over the next few years? The topoisomerase I inhibitors market size has grown strongly in recent years. It will grow from $5.18 billion in 2024 to $5.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to healthcare infrastructure improvements, increasing global healthcare expenditure, higher diagnosis rates of cancer, increasing focus on precision oncology, and increasing funding for biotech startups. The topoisomerase I inhibitors market size is expected to see strong growth in the next few years. It will grow to $6.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing prevalence of cancer, expanding research and development, rising aware...

Space-Based Biopharmaceuticals Market 2025–2034 – M&A Strategies and Futuristic Drug Development Trends

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the space-based biopharmaceuticals industry over the next few years? The space-based biopharmaceuticals market size has grown rapidly in recent years. It will grow from $4.29 billion in 2024 to $4.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing demand for high-quality biopharmaceuticals, the rise of private companies in the space sector, growing financial commitment to space missions, the growth and functionality of space stations, and the expansion of space-based manufacturing. The space-based biopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $7.46 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the expansion of the...

Sclerotherapy Market Outlook 2025 – Growth Roadmap and Therapeutic Innovation Insights

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the sclerotherapy industry over the next few years? The sclerotherapy market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising prevalence of varicose veins, increasing aging population, growing demand for minimally invasive procedures, improved healthcare infrastructure, greater awareness of aesthetic treatments, and expanding insurance coverage for vein-related conditions. The sclerotherapy market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive procedures, rising pre...

Prebiotics in Infant Formula Market 2025–2034 – Global M&A Trends and Competitive Benchmarking

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the prebiotics for infant formula industry over the next few years? The prebiotics for infant formula market size has grown strongly in recent years. It will grow from $1.59 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing awareness about infant gut health, growing demand for organic baby food, rising prevalence of gastrointestinal issues in infants, increasing adoption of prebiotics in pediatric nutrition, and rising birth rates in developing countries. The prebiotics for infant formula market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing interest in microb...

Pharmaceutical Lipid-Based Excipients Market 2025 – Strategic Insights for Manufacturing Expansion

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the pharmaceutical lipid-based excipients industry over the next few years? The pharmaceutical lipid-based excipients market size has grown strongly in recent years. It will grow from $1.69 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in prevalence of poorly water-soluble drugs, increase in demand for controlled and targeted drug release, growth in pharmaceutical investments, expand in use of oral solid dosage forms, heightened focus on improving drug bioavailability, and regulatory acceptance of lipid excipients in novel formulations. The pharmaceutical lipid-based excipients market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) o...

Personalized Dietary Supplements Market 2025–2034 – M&A Potential and Consumer Trend Insights

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the personalized dietary supplements industry over the next few years? The personalized dietary supplements market size has grown rapidly in recent years. It will grow from $8.47 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing consumer awareness of health and wellness, rising demand for personalized nutrition, rise in technological advancements in data analysis and genetic testing, increasing focus on mental health and cognitive function, rise in disposable income and willingness to spend on health products. The personalized dietary supplements market size is expected to see rapid growth in the next few years. It will grow to $14.49 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the fo...

Pancreatic Cancer Precision Medicine Market 2025 – Strategic Forecasts and Clinical Innovation Mapping

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the pancreatic cancer precision medicine industry over the next few years? The pancreatic cancer precision medicine market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.58 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to rise in incidence of pancreatic cancer, growth in understanding of tumor heterogeneity, increase in investment in oncology research, expand in availability of biomarker-driven therapies, improved diagnostic tools for early detection, and rise in adoption of personalized treatment approaches. The pancreatic cancer precision medicine market size is expected to see rapid growth in the next few years. It will grow to $1.08 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in ...

Online Virtual Dental Services Market 2025–2034 – M&A and Tech-Driven Growth Analysis

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the online virtual dental service industry over the next few years? The online virtual dental service market size has grown rapidly in recent years. It will grow from $3.27 billion in 2024 to $3.90 billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to rising demand for convenient dental care, growing acceptance of digital healthcare services, increasing health awareness among millennials and Gen Z, growing urbanization and time-constrained lifestyles, and growth in the aging population. The online virtual dental service market size is expected to see rapid growth in the next few years. It will grow to $7.75 billion in 2029 at a compound annual growth rate (CAGR) of 18.7%. The growth in the forecast period can be attributed to rise in cosmetic dental concerns,...

Neuroplasticity Market Growth Outlook 2025 – Innovation Trends and Strategic Expansion Insights

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the neuroplasticity industry over the next few years? The neuroplasticity market size has grown exponentially in recent years. It will grow from $5.34 billion in 2024 to $6.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.4%. The growth in the historic period can be attributed to rising interest in brain-computer interface technologies, increasing funding for neuroscience research, a rise in mental health concerns globally, increasing clinical validation of neuroplasticity-based therapies, and rising use of digital therapeutics in cognitive care. The neuroplasticity market size is expected to see exponential growth in the next few years. It will grow to $15.18 billion in 2029 at a compound annual growth rate (CAGR) of 23.2%. The growth in the forecast period can be attributed to growing integration of AI in n...

MSI-H and dMMR Testing Market Report 2025–2034 – Precision Oncology M&A and Competitive Trends

 Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What is the anticipated market size of the msi-h and dmmr industry over the next few years? The MSI-H and dMMR market size has grown exponentially in recent years. It will grow from $6.15 billion in 2024 to $7.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to rising incidence of colorectal and endometrial cancers, expanded genetic screening programs, growing clinical adoption of MSI testing, increasing awareness of hereditary cancer syndromes, and a rise in liquid biopsy adoption. The MSI-H and dMMR market size is expected to see exponential growth in the next few years. It will grow to $17.40 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to increasing demand for personalized cancer therapies, expanding applications of ...